Stockreport

Neuron23 Unveils Groundbreaking Phase 2 Trial in Early Parkinson's Disease [Yahoo! Finance]

Quest Diagnostics Incorporated  (DGX) 
Last quest diagnostics incorporated earnings: 4/22 06:45 am Check Earnings Report
US:NYSE Investor Relations: ir.questdiagnostics.com
PDF Global Phase 2 clinical trial leverages Roche-developed digital biomarker as primary endpoint for enhanced precision and efficiency over traditional clinical rating sca [Read more]